1. Abadi M, Agarwal, A, Barham, P, Brevdo, E, Chen, Z, Citro, C, Corrado, G S, Davis, A, Dean J, Devin, M, Ghemawat, S, Goodfellow, I, Harp, A, Irving, G, Isard, M, Jozefowicz, R, Jia, Y, Kaiser, L, Kudlur, M, Levenburg, J, Mane, D, Schuster, M, Monga, R, Moore, S, Murray, D, Olah, C, Shlens, J, Steiner, B, Sutskever, I, Talwar, K, Tucker, P, Vahoucke, V, Vasudevan, C, Viegas, F, Vinyals, O, Warden, P, Wattenerg, M, Wicke, M, Yu, Y, and Zheng, X (2015). TensorFlow: large-scale machine learning on heterogenous systems. Software available from
tensorflow.org
.
2. Alptekin K, Akvardar Y, Kivircik Akdede BB, Dumlu K, Işik D, Pirinçci F, Yahssin S, Kitiş A (2005). Is quality of life associated with cognitive impairment in schizophrenia? Prog Neuro-Psychopharmacol Biol Psychiatry 29(2):239–244. Epub 2004 Dec 23. PubMed PMID: 15694230.
3. Anderson G, Berk M, Dodd S, Bechter K, Altamura AC, Dell'osso B, Kanba S, Monji A, Fatemi SH, Buckley P, Debnath M, Das UN, Meyer U, Müller N, Kanchanatawan B, Maes M (2013) Immuno-inflammatory, oxidative and nitrosative stress, and neuroprogressive pathways in the etiology, course and treatment of schizophrenia. Prog Neuro-Psychopharmacol Biol Psychiatry 42:1–4.
https://doi.org/10.1016/j.pnpbp.2012.10.008
. Epub 2012 Oct 18. PubMed PMID: 23085074.
4. Anderson G, Maes M (2013) Schizophrenia: linking prenatal infection to cytokines, the tryptophan catabolite (TRYCAT) pathway, NMDA receptor hypofunction, neurodevelopment and neuroprogression. Prog Neuropsychopharmacol Biol Psychiatry 42: 5–19.
https://doi.org/10.1016/j.pnpbp.2012.06.014
. Epub 2012 Jul 16. Review. PubMed PMID: 22800757.
5. Andreasen NC (1989) The scale for the assessment of negative symptoms (SANS): conceptual and theoretical foundations. Br J Psychiatry Suppl 7:49–58